Literature DB >> 3418494

Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.

S C Tsao1, Y Sugiyama, Y Sawada, T Iga, M Hanano.   

Abstract

We previously found that the uptake of warfarin in the presence of albumin by perfused rat liver could not be explained simply by the unbound warfarin concentration. The aim of the present study is to develop a kinetic model to account for this albumin-mediated uptake of warfarin. Single circulation indicator dilution studies on warfarin uptake were carried out in the isolated perfused rat liver in the absence and presence of various concentrations of bovine serum albumin (BSA) in the perfusate. A distributed model was fitted to the dilution data and the estimates of the influx, efflux, and sequestration rate constants were obtained. The results showed that the predicted concentration of the unbound warfarin is not high enough to explain the observed uptake rate; the liver cell surface appears to reduce the binding affinity of warfarin for BSA to 1/20 of that observed in vitro. A kinetic model which considers the interaction between albumin and the liver cell surface was fitted to the uptake rates of warfarin over a wide range of BSA concentration. The model gave a dissociation constant of the cell surface for albumin of 160 microM, which is comparable with those reported by others for the hepatic extractions of free fatty acids and rose bengal. Based on this kinetic model, the contributions of the unbound and bound warfarin to its hepatic uptake were estimated, and the bound warfarin was found to contribute most in the physiological albumin concentration range.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418494     DOI: 10.1007/BF01062259

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  30 in total

1.  Analysis of multiple indicator dilution curves for estimation of renal tubular transport parameters.

Authors:  Y Sawada; N Itoh; Y Sugiyama; T Iga; M Hanano
Journal:  Comput Methods Programs Biomed       Date:  1985-05       Impact factor: 5.428

2.  Comparative pharmacokinetics of coumarin anticoagulants XLIII: Concentration-dependent hepatic uptake of warfarin in rats.

Authors:  K Takada; G Levy
Journal:  J Pharm Sci       Date:  1979-12       Impact factor: 3.534

3.  Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances.

Authors:  R Weisiger; J Gollan; R Ockner
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

Review 4.  Effects of unstirred layers on membrane phenomena.

Authors:  P H Barry; J M Diamond
Journal:  Physiol Rev       Date:  1984-07       Impact factor: 37.312

5.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

6.  Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.

Authors:  V Maes; Y Engelborghs; J Hoebeke; Y Maras; A Vercruysse
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

7.  Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method.

Authors:  S C Tsao; Y Sugiyama; Y Sawada; S Nagase; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

8.  Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface.

Authors:  E L Forker; B A Luxon
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Influence of free fatty acid anion on the binding of warfarin to cytoplasmic proteins from rat liver.

Authors:  L Charest-Boule; S Chakrabarti; J Brodeur
Journal:  Chem Biol Interact       Date:  1980-01       Impact factor: 5.192

10.  Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.

Authors:  W M Pardridge; R Sakiyama; G Fierer
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

View more
  8 in total

Review 1.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple-indicator dilution method.

Authors:  H Sato; Y Sugiyama; Y Sawada; T Iga; S Sakamoto; T Fuwa; M Hanano
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation.

Authors:  Christine M Bowman; Hideaki Okochi; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2019-01-23       Impact factor: 3.922

4.  Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.

Authors:  R K Dubey; C B McAllister; M Inoue; G R Wilkinson
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

6.  Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.

Authors:  J M Díaz-García; A M Evans; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

Review 7.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

8.  Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data.

Authors:  Jaydeep Yadav; Mehdi El Hassani; Jasleen Sodhi; Volker M Lauschke; Jessica H Hartman; Laura E Russell
Journal:  Drug Metab Rev       Date:  2021-05-25       Impact factor: 6.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.